Loading...
Thumbnail Image
Publication

Prescription Drugs Are More Expensive in Rep. Waxman's Congressional District in California than in Canada, Europe, and Japan

House Committee on Government Reform
Special Investigations Division
Abstract
The Special Investigations Division of the House Committee on Government Reform examined the financial impact of high prescription drug prices on senior citizens in the United States, particularly those without Medicare coverage for drugs. The report attributes the high drug prices to price discrimination by manufacturers, a practice not addressed in the U.S. compared to other developed countries. The investigation specifically focuses on Rep. Waxman's congressional district, comparing the prices paid by seniors for popular brand-name prescription drugs with prices in Canada, France, Germany, Italy, Japan, and the United Kingdom.
Date
2002-07-01
Document Type
House Minority Staff Report
Serial Number
Document Length
14 pages
Congress
107
Relation
DOI
Keywords
Staff Reports
PAP Major Code
3: Health
PAP Minor Code
335: Prescription Drug Coverage and Costs
Related Hearings
Press Releases and Contextual Information